Cargando…

Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection

For sentinel lymph node biopsy (SLNB), a combination of dye-guided and γ-probe-guided methods is the most commonly used technique. However, the number of institutes in which the γ-probe-guided method is able to be performed is limited, since special equipment is required for the method. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: TAKAMARU, TOMOKO, KUTOMI, GORO, SATOMI, FUKINO, SHIMA, HIROAKI, OHNO, KEISUKE, KAMESHIMA, HIDEKAZU, SUZUKI, YASUYO, OHMURA, TOUSEI, TAKAMARU, HIROYUKI, NOJIMA, MASANORI, MORI, MITSURU, HIRATA, KOICHI
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881064/
https://www.ncbi.nlm.nih.gov/pubmed/24396425
http://dx.doi.org/10.3892/etm.2013.1445
_version_ 1782298154315546624
author TAKAMARU, TOMOKO
KUTOMI, GORO
SATOMI, FUKINO
SHIMA, HIROAKI
OHNO, KEISUKE
KAMESHIMA, HIDEKAZU
SUZUKI, YASUYO
OHMURA, TOUSEI
TAKAMARU, HIROYUKI
NOJIMA, MASANORI
MORI, MITSURU
HIRATA, KOICHI
author_facet TAKAMARU, TOMOKO
KUTOMI, GORO
SATOMI, FUKINO
SHIMA, HIROAKI
OHNO, KEISUKE
KAMESHIMA, HIDEKAZU
SUZUKI, YASUYO
OHMURA, TOUSEI
TAKAMARU, HIROYUKI
NOJIMA, MASANORI
MORI, MITSURU
HIRATA, KOICHI
author_sort TAKAMARU, TOMOKO
collection PubMed
description For sentinel lymph node biopsy (SLNB), a combination of dye-guided and γ-probe-guided methods is the most commonly used technique. However, the number of institutes in which the γ-probe-guided method is able to be performed is limited, since special equipment is required for the method. In this study, SLNB with the dye-guided method alone was evaluated, and the clinicopathological characteristics were analyzed to identify any factors that were predictive of whether the follow-up axillary lymph node dissection (ALND) was able to be omitted. A total of 374 patients who underwent SLNB between 1999 and 2009 were studied. The SLN identification rate was analyzed, in addition to the false-positive and false-negative rates and the correlation between the clinicopathological characteristics and axillary lymph node metastases. The SLN was identified in 96.8% of cases, and, out of the patients who had SLN metastasis, 63.0% did not exhibit metastasis elsewhere. The sensitivity was 96.4% and the specificity was 100%. The false-negative rate was 3.6%. Univariate analyses revealed significant differences in the lymph vessel invasion (ly) status, nuclear grade (NG), maximum tumor size and the percentage of the area occupied by the tumor cells in the SLN (SLN occupation ratio) between the patients with and without non-SLN metastasis, indicating that these factors may be predictive of axillary lymph node metastasis. Multivariate analysis revealed that ly status was an independent risk factor for non-SLN metastasis. In conclusion, SLN with the dye-guided method alone provided a high detection rate. The study identified a predictive factor for axillary lymph node metastasis that may improve the patients’ quality of life.
format Online
Article
Text
id pubmed-3881064
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-38810642014-01-06 Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection TAKAMARU, TOMOKO KUTOMI, GORO SATOMI, FUKINO SHIMA, HIROAKI OHNO, KEISUKE KAMESHIMA, HIDEKAZU SUZUKI, YASUYO OHMURA, TOUSEI TAKAMARU, HIROYUKI NOJIMA, MASANORI MORI, MITSURU HIRATA, KOICHI Exp Ther Med Articles For sentinel lymph node biopsy (SLNB), a combination of dye-guided and γ-probe-guided methods is the most commonly used technique. However, the number of institutes in which the γ-probe-guided method is able to be performed is limited, since special equipment is required for the method. In this study, SLNB with the dye-guided method alone was evaluated, and the clinicopathological characteristics were analyzed to identify any factors that were predictive of whether the follow-up axillary lymph node dissection (ALND) was able to be omitted. A total of 374 patients who underwent SLNB between 1999 and 2009 were studied. The SLN identification rate was analyzed, in addition to the false-positive and false-negative rates and the correlation between the clinicopathological characteristics and axillary lymph node metastases. The SLN was identified in 96.8% of cases, and, out of the patients who had SLN metastasis, 63.0% did not exhibit metastasis elsewhere. The sensitivity was 96.4% and the specificity was 100%. The false-negative rate was 3.6%. Univariate analyses revealed significant differences in the lymph vessel invasion (ly) status, nuclear grade (NG), maximum tumor size and the percentage of the area occupied by the tumor cells in the SLN (SLN occupation ratio) between the patients with and without non-SLN metastasis, indicating that these factors may be predictive of axillary lymph node metastasis. Multivariate analysis revealed that ly status was an independent risk factor for non-SLN metastasis. In conclusion, SLN with the dye-guided method alone provided a high detection rate. The study identified a predictive factor for axillary lymph node metastasis that may improve the patients’ quality of life. D.A. Spandidos 2014-02 2013-12-11 /pmc/articles/PMC3881064/ /pubmed/24396425 http://dx.doi.org/10.3892/etm.2013.1445 Text en Copyright © 2014, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Articles
TAKAMARU, TOMOKO
KUTOMI, GORO
SATOMI, FUKINO
SHIMA, HIROAKI
OHNO, KEISUKE
KAMESHIMA, HIDEKAZU
SUZUKI, YASUYO
OHMURA, TOUSEI
TAKAMARU, HIROYUKI
NOJIMA, MASANORI
MORI, MITSURU
HIRATA, KOICHI
Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
title Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
title_full Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
title_fullStr Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
title_full_unstemmed Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
title_short Use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
title_sort use of the dye-guided sentinel lymph node biopsy method alone for breast cancer metastasis to avoid unnecessary axillary lymph node dissection
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881064/
https://www.ncbi.nlm.nih.gov/pubmed/24396425
http://dx.doi.org/10.3892/etm.2013.1445
work_keys_str_mv AT takamarutomoko useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT kutomigoro useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT satomifukino useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT shimahiroaki useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT ohnokeisuke useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT kameshimahidekazu useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT suzukiyasuyo useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT ohmuratousei useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT takamaruhiroyuki useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT nojimamasanori useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT morimitsuru useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection
AT hiratakoichi useofthedyeguidedsentinellymphnodebiopsymethodaloneforbreastcancermetastasistoavoidunnecessaryaxillarylymphnodedissection